E. A. Kotsyurbiy

E. A. Kotsyurbiy

Auto-generated profile, based on publicly available information

E. A. Kotsyurbiy

Pacific State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
LSLarisa M. Somova
Larisa M. Somova
EKE.A. Kotsyurbiy
E.A. Kotsyurbiy
EDE.I. Drobot
E.I. Drobot
ILI.N. Lyapun
I.N. Lyapun
Mikhail Yurievich ShchelkanovMikhail Yurievich Shchelkanov
Mikhail Yurievich Shchelkanov
Rapid development in 2020 of the COVID-19 pandemic caused by SARS-CoV-2 initially indicated signifi-cant involvement of the immune system. However, information on specific changes in organs of the immune system is still limited. A wide range of alterations was revealed in our study: from pronounced devastation of B-dependent and T-dependent zones of lymphoid tissue, reminiscent of changes in HIV infection at the AIDS stage, to hyperplasia of the tissue of lymph nodes and spleen of varying degrees. Analyzing the literature data, we focused on the fact that pathomorphological changes revealed in the autopsy studies of patients with a severe COVID-19 were accompanied by premortal lymphopenia in most cases. However, the cause of lymphopenia in COVID-19 has not yet been disclosed, authors of the review hypothesized that unregulated apoptosis of circulating lymphocytes is one of the potential lymphopenia inductors. Cytokine activation (“cytokine storm”) may be associated with lymphoid organs’ atrophy, which also contributes to a decrease in the circulating lymphocyte count. There is no doubt about the relevance of further identification of the immune cell apoptosis as one of the causes of lymphopenia and immune dysfunction in COVID-19 patients, which has prospects for pharmacological developments to manage lymphocytic apoptosis. Keywords: coronavirus infection, COVID-19, pathomorphology, lymphopenia, lymph nodes, spleen, lym-phocytic apoptosis

28 December 2020 in Pacific Medical Journal
Verified
Journal Article
Open access
PDF file
EKE. A. Kotsyrbiy
E. A. Kotsyrbiy
YTY. N. Tychonov
Y. N. Tychonov
INI. V. Nazarova
I. V. Nazarova
IRI. O. Reznichek
I. O. Reznichek
ATA. N. Tumanina
A. N. Tumanina
ЯТЯ. Н. Тихонов
Я. Н. Тихонов
Liquid-based material and traditional pap smears got during fine-needle biopsies of different tumors were analyzed. Cell-cycle blocks and monolayer pills were made from liquid-based material depending on the amount of cell structures. Original method using donor thrombocyte mass was implemented to create cell-cycle blocks, especially to condense and consolidate the sediment after centrifugation. After taking pancreas punctures different medical institutions in Vladivostok managed to form cell-cycle blocks in 71 cases from 2017 to 2019. In 9 cases (12.7%) the material was found to be diagnostically noninformative, in 15 cases (21.2%) – sufficient for morphological research, but inappropriate for immunohistochemistry. In 47 cases (66.1%) 206 immunohistochemical tests were made using 34 types of biomarkers.

1 January 2022 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
LSLarisa M. Somova
Larisa M. Somova
EKE.A. Kotsyurbiy
E.A. Kotsyurbiy
EDE.I. Drobot
E.I. Drobot
NKNatalya Krylova
Natalya Krylova
ILI.N. Lyapun
I.N. Lyapun
Mikhail Yurievich ShchelkanovMikhail Yurievich Shchelkanov
Mikhail Yurievich Shchelkanov
Introduction. When studying COVID-19 pathology, considerable attention is paid to the damage to the respiratory and cardiovascular systems, which are associated with the manifestation of the infection. Data on changes in the organs of the lymphatic system are yet scarce. To date, COVID-19 is sure to cause the dysfunction of the immune system; however, information about the damage to the lymph nodes is ambiguous. The aim of the study was to characterize morphological changes in the hilar lymph nodes of patients who died from a new coronavirus infection COVID-19 in Vladivostok in 2021. Materials and methods. A morphological study of the lymph nodes was performed in 20 patients who died from the new coronavirus infection, diagnosed in vivo using a PCR test. The controls were patients who did not have diseases of the hematopoietic and lymphoid tissue in their medical histories but who died a violent death. The material for histological examination was processed according to generally accepted methods. Results. In all patients, we identified lymphadenopathy with hypoplasia of lymphoid tissue of varying severity. In the cortex, lymphatic follicles were detected, mainly without light (germinal) centers, as well as follicles with a pronounced rarefaction of cells and exposure to the reticular stroma, with no visualization of the paracortical zone. According to the severity of reactive changes in the T- and B-dependent zones of the lymph nodes, we distinguished two types of lymphadenopathy: 1) mixed follicular type; 2) follicular involution with lymphoid depletion. Conclusion. Pathological changes in the hilar lymph nodes of the lungs in patients who died from COVID-19 indicated immunosuppressive effects of the SARS-CoV-2. The pathologic changes in lymph nodes manifested with lymphocytic depletion in T- and B-dependent zones. This indicates a deficiency of cellular and humoral immunity in moderate and severe COVID-19. Keywords: coronavirus infection, COVID-19, pathomorphology, lymph nodes, lymphocytic depletion, immunodeficiency

26 November 2024 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
VNV. A. Nevzorova
V. A. Nevzorova
ATA. V. Tal'KO
A. V. Tal'KO
EKE. A. Kotsyurbiy
E. A. Kotsyurbiy
VPV. Yu. Parinov
V. Yu. Parinov
ZPZ. E. Putiy
Z. E. Putiy
Aim: To study the variants of morphological changes in the lung using material from pathological autopsies of patients with blood diseases who died of COVID-19.Materials and Methods: A retrospective morphological analysis of histological preparations of lung tissue was performed in a cohort of patients with blood diseases, using standard histological staining with haematoxylin and eosin and assessment of the state of alveolocytes of type 1 and 2, Mallory and Van Gieson staining to assess the state of connective tissue. The leukocyte profile of the lung tissue was studied by immunohistochemical analysis using antibodies of differentiation clones (CD) 4, 8, 20, 34 and collagen type IV.Results: 22 fatal cases of patients with blood diseases who died of COVID-19 were analysed (13 men and 9 women); the mean age was 63 years. The selected cohort included non-neoplastic (myelodysplastic syndrome with multilineage dysplasia) and neoplastic blood disorders (chronic lymphocytic leukaemia, acute myeloid leukaemia, acute lymphoblastic leukaemia, multiple myeloma). Morphometric analysis revealed certain differences in the condition of the lung tissue. In the group with myelodysplasia, the morphological picture of lung tissue damage in COVID-19 is characterised by the destruction of alveolar tissue, the presence of single alveolocytes and the absence of neutrophils and macrophages. In chronic lymphocytic leukaemia, a disruption in the formation of hyaline membranes and the development of mycetomas, the appearance of lymphocytes of different sizes were observed. In lymphoma, the development of thrombus formation was observed against a background of decollagenisation of the vessel wall. In multiple myeloma, multinucleated alveolocytes formed as a result of viral metamorphosis were seen. In untreated patients, blasts were detected at the onset of acute myeloid leukaemia. Despite the diversity of the cohort, the immune response showed a universal response in the form of disappearance of CD4 and expression of CD8 and CD34 leukocytes in all cases considered. An individual feature in multiple myeloma was the positive expression of CD20+ leukocytes in lung tissue.Conclusions: Lung damage in COVID-19 is characterised by differences in the state of the morphological picture depending on the oncohematological disease and the universality of the immune response, with a difference in patients with multiple myeloma in the form of increased expression of CD20+, probably due to the pathogenesis of myeloma and the accumulation of pathological clones of leukocytes.